<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="been tested widely for the newly emerged SARS-CoV-2. Remdesivir and" exact="chloroquine" post="were found highly effective in vitro for the control"/>
 <result pre="infection (44). Treatment with remdesivir alone or in combination with" exact="chloroquine" post="or interferon beta was found effective against COVID-19 infection."/>
 <result pre="hence could be a suitable therapeutic strategy for SARS-CoV-2. (35)" exact="Ribavirin" post="Targets RdRp (RNAâ€‘dependent RNA polymerase) enzyme to inhibit synthesis"/>
 <result pre="pathogenic viruses, thus might be used against SARS-CoV-2. (62) Hexamethylene" exact="amiloride" post="Targets viral envelope to inhibit ion channel activity Has"/>
 <result pre="inducers or recombinant interferons (1). Recombinant interferons such as interferon" exact="alpha" post="and interferon beta that have been tested against SARS-CoV"/>
 <result pre="combination with other potential antiviral drugs, including remdesivir. Both interferon" exact="alpha" post="and beta inhibit viral replication (1). The use of"/>
 <result pre="synergistic effects against SARS-CoV-2. In addition, calcineurin inhibitors such as" exact="cyclosporine" post="(53), in combination with antibiotics and traditional Chinese medicines,"/>
 <result pre="scenario of pneumonia in Wuhan, China. Broad-range combinational therapies, including" exact="lopinavir" post="and interferon antiviral peptides, can also be evaluated and"/>
 <result pre="CaoR, ZhangL, YangX, LiuJ, XuM, ShiZ, HuZ, ZhongW, XiaoG2020Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="doi:10.2174/1570163814666170727130003.28748751 65.Ma-LauerY, ZhengY, MaleÅ¡eviÄ‡M, von BrunnB, FischerG, von BrunnA2020Influences of" exact="cyclosporin A" post="and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid"/>
</results>
